UPDATE: AngioDynamics (ANGO) Tops Q3 EPS by 1c; Cuts FY EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Piper Jaffray Assumes AngioDynamics (ANGO) at Neutral
April 8, 2016 6:38 AM EDTPiper Jaffray assumes coverage on AngioDynamics (NASDAQ: ANGO) with a Neutral rating and a price target of $12.00.
Analyst Brooks West commented, "We are assuming coverage of AngioDynamics, Inc. with a Neutral rating and $12 PT. ANGO reported fiscal 3Q16 earnings this evening and... More
